HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuro Kanda Selected Research

dihydropyrimidinase

1/2020Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.
5/2015Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.
8/2014Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuro Kanda Research Topics

Disease

87Stomach Neoplasms (Stomach Cancer)
06/2022 - 08/2014
85Neoplasms (Cancer)
06/2022 - 09/2008
39Neoplasm Metastasis (Metastasis)
06/2022 - 08/2011
37Hepatocellular Carcinoma (Hepatoma)
08/2022 - 09/2008
24Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 01/2011
15Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 04/2014
14Esophageal Squamous Cell Carcinoma
11/2022 - 02/2016
13Adenocarcinoma
05/2021 - 03/2010
12Pancreatic Fistula (Pancreatic Fistulas)
01/2021 - 06/2014
11Melanoma (Melanoma, Malignant)
06/2020 - 12/2013
9Lymphatic Metastasis
04/2022 - 08/2014
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 11/2015
6Esophageal Neoplasms (Esophageal Cancer)
12/2022 - 02/2014
6Colonic Neoplasms (Colon Cancer)
08/2021 - 01/2017
5Breast Neoplasms (Breast Cancer)
01/2022 - 06/2017
5Fibrosis (Cirrhosis)
01/2021 - 01/2014
4Inflammation (Inflammations)
01/2020 - 09/2014
4Carcinogenesis
01/2018 - 02/2014
3Disease Progression
01/2020 - 05/2015
3Neoplasms, Cystic, Mucinous, and Serous
01/2018 - 05/2015
3Hemorrhage
01/2016 - 11/2015
3Infections
05/2015 - 11/2014
2Liver Diseases (Liver Disease)
08/2022 - 01/2018
2Margins of Excision
01/2021 - 05/2020
2Anastomotic Leak
02/2020 - 08/2018
2Pneumonia (Pneumonitis)
10/2019 - 10/2019
2Abdominal Abscess
08/2018 - 09/2015
2Sarcopenia
03/2017 - 06/2016
2Body Weight (Weight, Body)
03/2016 - 07/2014
2Pancreatitis
05/2015 - 11/2013
2Pancreatic Cyst
05/2015 - 07/2013

Drug/Important Bio-Agent (IBA)

52Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2014
36Messenger RNA (mRNA)IBA
06/2022 - 01/2014
14AntigensIBA
08/2021 - 12/2013
13Proteins (Proteins, Gene)FDA Link
02/2021 - 11/2011
9Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021 - 04/2014
6MicroRNAs (MicroRNA)IBA
11/2022 - 09/2015
6AlbuminsIBA
08/2022 - 11/2011
6Carcinoembryonic AntigenIBA
04/2022 - 09/2014
6CarbohydratesIBA
01/2020 - 09/2014
5Cisplatin (Platino)FDA LinkGeneric
12/2022 - 01/2017
5Fluorouracil (Carac)FDA LinkGeneric
12/2022 - 12/2016
5BilirubinIBA
08/2022 - 01/2018
5Capecitabine (Xeloda)FDA Link
01/2021 - 10/2015
4Protein Isoforms (Isoforms)IBA
01/2022 - 09/2008
4Synaptotagmins (Synaptotagmin)IBA
10/2021 - 01/2018
4Monoclonal AntibodiesIBA
01/2021 - 12/2016
4Tumor Biomarkers (Tumor Markers)IBA
06/2020 - 01/2015
4Bevacizumab (Avastin)FDA Link
01/2018 - 10/2015
4SecretinFDA Link
05/2015 - 06/2013
3Pharmaceutical PreparationsIBA
01/2022 - 10/2015
3Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 11/2018
3RNA (Ribonucleic Acid)IBA
07/2021 - 01/2019
3Indicators and Reagents (Reagents)IBA
03/2020 - 02/2015
3dihydropyrimidinaseIBA
01/2020 - 08/2014
3Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 04/2014
2Docetaxel (Taxotere)FDA Link
12/2022 - 12/2021
2Carrier Proteins (Binding Protein)IBA
06/2022 - 05/2015
2squamous cell carcinoma-related antigenIBA
04/2022 - 04/2020
2Small Interfering RNA (siRNA)IBA
01/2022 - 03/2019
2Circular RNAIBA
01/2022 - 01/2021
2Estrogen ReceptorsIBA
10/2021 - 11/2020
26-methyladenineIBA
07/2021 - 12/2020
2N-methyladenosineIBA
07/2021 - 12/2020
2Transcription Factors (Transcription Factor)IBA
01/2021 - 03/2016
2AntibodiesIBA
01/2021 - 01/2020
2GTP-Binding Proteins (G-Protein)IBA
01/2021 - 11/2020
2N-acetyltalosaminuronic acid (NAT)IBA
12/2020 - 05/2020
2S-1 plus cisplatinIBA
11/2020 - 01/2020
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
04/2020 - 01/2019
2Biological ProductsIBA
01/2019 - 04/2018
2Blood Coagulation Factors (Coagulation Factor)IBA
02/2017 - 11/2014
2Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
02/2017 - 09/2016
2XELOXIBA
01/2017 - 12/2016
2Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
08/2016 - 03/2016
2Cell Adhesion MoleculesIBA
02/2016 - 08/2014
2Vitamin KFDA Link
12/2015 - 05/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2015 - 09/2008
2Epidermal Growth Factor (EGF)IBA
01/2013 - 03/2010
2fibulinIBA
08/2011 - 03/2010
1pegfilgrastim (Neulasta)FDA Link
12/2022
1Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2022
1Lysosomal Membrane ProteinsIBA
01/2022
1PhosphofructokinasesIBA
01/2022
1Fetal Proteins (Fetoprotein)IBA
05/2021

Therapy/Procedure

41Gastrectomy
06/2022 - 09/2015
25Therapeutics
01/2022 - 08/2011
16Adjuvant Chemotherapy
01/2022 - 08/2014
14Pancreatectomy
01/2021 - 03/2010
13Lymph Node Excision (Lymph Node Dissection)
05/2021 - 08/2011
12Drug Therapy (Chemotherapy)
01/2022 - 01/2011
11Esophagectomy
08/2022 - 03/2015
10Neoadjuvant Therapy
05/2021 - 08/2011
9Pancreaticoduodenectomy
01/2021 - 11/2011
7Hepatectomy
09/2017 - 09/2014
4Length of Stay
10/2019 - 11/2015
3Blood Transfusion (Blood Transfusions)
06/2019 - 01/2016
3Enteral Nutrition (Feeding, Tube)
12/2015 - 05/2015
2Operative Surgical Procedures
11/2018 - 01/2012
2Laparotomy
05/2017 - 01/2011